Literature DB >> 22409863

A primary signet ring cell carcinoma of the prostate with bone metastasis with impressive response to FOLFOX and cetuximab.

Ana Milena Roldán1, Natalia Fernández Núñez, Enrique Grande, Augusto Álvarez García, Luis M Antón-Aparicio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22409863     DOI： 10.1016/j.clgc.2012.01.006

Source DB:  PubMed          Journal:  Clin Genitourin Cancer        ISSN： 1558-7673            Impact factor:   2.872


× No keyword cloud information.
  4 in total

1.  Primary signet ring cell carcinoma of the prostate treated by radical cystoprostatectomy and chemoradiotherapy.

Authors:  Sun Wook Kim; Woohyun Kim; Yong-Hyun Cho; Tae-Jung Kim; Insuk Woo; Dong Wan Sohn
Journal:  Can Urol Assoc J       Date:  2016-05-12       Impact factor: 1.862

2.  Primary Signet Ring Cell Carcinoma of the Prostate: A Rare Case Report.

Authors:  Alper Gök; Can Tuygun; Müge Akmansu; Ayşegül Aksakal Uslu; Ibrahim Güven Kartal; Fatih Sandikçi; Osman Raif Karabacak; Azmi Levent Sağnak; Hikmet Topaloğlu; Hamit Ersoy
Journal:  J Clin Med       Date:  2018-08-15       Impact factor: 4.241

3.  Diagnosis and Management of Primary Prostatic Signet Ring Cell Carcinoma: Single-Center Experience.

Authors:  Pu Li; Zihan Zhou; Meiling Bao; Jie Li; Xiaoxin Meng; Bianjiang Liu; Min Tang
Journal:  Am J Mens Health       Date:  2022 Mar-Apr

4.  Immunohistochemical analysis of PD-L1 and tumor-infiltrating immune cells expression in the tumor microenvironment of primary signet ring cell carcinoma of the prostate.

Authors:  Qi-Liang Teng; Xin-Rui Yang; Shuang Wen; Zhi-Hong Dai; Hong-Long Wang; Tian-Qing Liu; Liang Wang; Bo Fan; Zhi-Yu Liu
Journal:  Asian J Androl       Date:  2022 Sep-Oct       Impact factor: 3.054
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.